The Foreign-Trade Zones Board has recently announced the following actions. Click here for more information on how FTZs can benefit your business, or contact attorney Scott Taylor at (212) 549-0153 or via email.

- received separate notifications of proposed production activity regarding a COVID-19 vaccine at the Wyeth Pharmaceuticals LLC facility within FTZ 27 in Andover, Mass., and the Exela Pharma Sciences LLC facility within FTZ 57 in Lenoir, N.C. (comments due by Sept. 7)

- received a notification of proposed production activity regarding ferries, yachts, research vessels, and aluminum hulls and hull modules at the Shipbuilders of Wisconsin Inc. facility within FTZ 167 in Manitowoc, Wis. (comments due by Sept. 7)

- received a notification of proposed production activity regarding automobiles and cargo trucks at the Hyundai Motor Manufacturing Alabama LLC facility within FTZ 222 in Montgomery, Ala. (comments due by Sept. 7)

- received a request to remove a restriction requiring admission in privileged foreign status for continuous filament polypropylene yarn used to make woven area rugs at the Flemish Master Weavers facility within FTZ 186 in Sanford, Maine (comments due by Sept. 19)

- approved the expansion of subzone 168G at the Sager Electronics facility in Lewisville, Texas

- approved production under zone procedures, limited to foreign-status prep razors (disposable, plastic handle with steel blades, used for surgery preparation), at the Swafford Warehousing Inc. facility within FTZ 38 in Greer, S.C.

- approved the establishment of subzone 21I at the DMA Sales LLC facilities in Marion and Nichols, S.C.

Copyright © 2024 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 


Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.